REG - Agronomics Limited - Liberation Bioindustries Series A1 equity round

AgronomicsAnnouncement

19/12/2025 09:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251219:nRSS2956Ma&default-theme=true

RNS Number : 2956M  Agronomics Limited  19 December 2025

19 December 2025

Agronomics Limited

 ("Agronomics (https://www.agronomics.im/) " or the "Company")

 

Liberation Bioindustries achieves first close of their Series A1 equity round

Agronomics (LSE: ANIC), the leading listed company focused on clean food, is
pleased to announce that its portfolio company Liberation Bioindustries, Inc
("Liberation Bioindustries") has closed the first tranche of its Series A1
equity round.

Liberation Bioindustries is in the final stages of constructing its first
commercial-scale, purpose-built, precision fermentation biomanufacturing
facility with a capacity of 600,000 liters and a fully dedicated downstream
process. The plant will produce a range of bio-based materials, specifically
protein and other building block ingredients for food at a scale and cost that
will fill a pressing need among both new and established consumer packaged
goods companies and other industrial manufacturers.

Recent partnerships highlight the company's growing commercial footprint. In
May 2025, Liberation Bioindustries announced plans to produce Vivitein™ BLG,
a dairy protein developed by Dutch startup Vivici, at commercial volumes. In
April 2025, the company revealed a strategic partnership with Topian, NEOM's
food company, to co-develop a cutting-edge fermentation facility in the
Kingdom of Saudi Arabia.

Jim Mellon, Executive Chair of Agronomics said:

"We are delighted to deepen our partnership with Liberation Bioindustries.
This reflects our strong conviction in the company's approach, its highly
capable team, and the role its infrastructure will play in reshaping how key
ingredients used in foods across the world are made. There is no doubt that
Liberation's positive impact will be felt across the US once the facility is
completed, with partners ready to come on board and start producing
ingredients immediately, demonstrating how precision fermentation can bolster
food and supply chain security.

The Series A1 equity round includes the conversion (capital plus accrued
interest to conversion date) of all Convertible Loan Note instruments held by
Agronomics, into Series A1 shares, increasing the number of A1 shares held
from 6,834,147 to 16,538,437.

To date, Agronomics has invested a total of US$ 27 million (c. £21.9 million)
in Liberation Bioindustries (formerly Liberation Labs) which, subject to
audit, is, as a result of this fundraise by Liberation Bioindustries, now
carried at US$ 46.8 million (c.£35 million), an increase of US$ 2.5 million.
This position represents c. 23% of Agronomics' last stated Net Asset Value as
at 30 September 2025. New Agrarian Company Limited, an affiliate company of
Agronomics, will be investing US$ 2.5 million in this Series A1 equity round.

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic
Law by virtue of the European Union (Withdrawal) Act 2018. Upon the
publication of this announcement, this inside information is now considered to
be in the public domain.

About Agronomics

Agronomics is a leading London-listed company focused on investment
opportunities within the field of cellular agriculture. The Company has
established a portfolio of over 20 companies developing technologies that
produce food and materials historically derived from animals, offering
solutions for improved sustainability, human health, and food security.

A full list of Agronomics' portfolio companies is available at
www.agronomics.im (http://www.agronomics.im/) .

For further information, please contact:

 

 Agronomics Limited   Beaumont              Cavendish Capital     33Seconds

                      Cornish Limited       Markets               Limited

                                            Limited
 The Company          Nomad                 Broker                Public Relations
 Jim Mellon           Roland Cornish        Giles Balleny         Jack Ferris

 Denham Eke           James Biddle          Michael Johnson       Amber Carr
 +44 (0) 1624 639396  +44 (0) 207 628 3396  +44 (0) 207 397 8900  agronomics@33seconds.co

 info@agronomics.im

 

Nominated Adviser Statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated
Adviser and is authorised and regulated in the United Kingdom by the Financial
Conduct Authority. Beaumont Cornish's responsibilities as the Company's
Nominated Adviser, including a responsibility to advise and guide the Company
on its responsibilities under the AIM Rules for Companies and AIM Rules for
Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont
Cornish is not acting for and will not be responsible to any other persons for
providing protections afforded to customers of Beaumont Cornish nor for
advising them in relation to the proposed arrangements described in the
announcement or any matter referred to in it.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCKKLBFELLFFBB



            Copyright 2019 Regulatory News Service, all rights reserved